DNLI
Price
$14.45
Change
+$0.05 (+0.35%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
2.09B
36 days until earnings call
FMED
Price
$23.76
Change
-$0.18 (-0.75%)
Updated
Jun 25, 04:59 PM (EDT)
Net Assets
51.98M
Interact to see
Advertisement

DNLI vs FMED

Header iconDNLI vs FMED Comparison
Open Charts DNLI vs FMEDBanner chart's image
Denali Therapeutics
Price$14.45
Change+$0.05 (+0.35%)
Volume$48.5K
Capitalization2.09B
Fidelity Disruptive Medicine ETF
Price$23.76
Change-$0.18 (-0.75%)
VolumeN/A
Net Assets51.98M
DNLI vs FMED Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. FMED commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and FMED is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (DNLI: $14.40)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green while.

  • DNLI’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish.

  • DNLI’s TA Score: 3 bullish, 5 bearish.

Price Growth

DNLI (@Biotechnology) experienced а +2.78% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIFMED
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AAAGX18.600.30
+1.64%
Thrivent Large Cap Growth A
RMFEX58.440.41
+0.71%
American Funds American Mutual R4
ACGGX18.690.08
+0.41%
American Century Global Gold A
CLSUX25.86N/A
N/A
ClearBridge Sustainability Leaders A
STRSX27.44N/A
N/A
Sterling Capital Special Opps R6

FMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, FMED has been loosely correlated with NTLA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if FMED jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMED
1D Price
Change %
FMED100%
+2.48%
NTLA - FMED
65%
Loosely correlated
+3.68%
DNLI - FMED
61%
Loosely correlated
+5.73%
TECH - FMED
61%
Loosely correlated
+1.42%
TMO - FMED
60%
Loosely correlated
+1.04%
TXG - FMED
60%
Loosely correlated
+0.93%
More